18F-Fluoride Positron Emission Tomography and Positron Emission Tomography/Computed Tomography
Section snippets
18F-Fluoride Preparation
18F-Fluoride was produced by the 18O(p,n)18F nuclear reaction in 2 mL of enriched 18O water as a target and then transferred into a fluorination module by a flow of argon. After trapping, it was loaded on an anion exchange column, dried, eluted with 1 mL of K2CO3 solution (5 mg/mL), and transferred to the reactor. After the addition of 1 mL of sterile water, the solution was heated to 120°C (2 minutes), followed by evaporation under reduced pressure. After the temperature of the solution was
Assessment of Metabolic Bone Diseases and Other Pathological Bone Conditions Using Quantitative 18F-Fluoride Imaging
In vivo assessment of 18F-fluoride kinetics allows characterization of bone disease as well as monitoring response to therapy. Specific regions in the skeleton can be individually assessed. This section will address the clinical role of quantitative 18F-fluoride PET.
Metabolic Bone Disease: Paget, Osteoporosis, and Renal Osteodystrophy
Several groups have investigated the kinetics of 18F-fluoride in Paget’s disease.19, 24 In Pagetic bones, Ki values were increased more than 3-fold increased and k1 values were increased more than 2-fold, reflecting increased
Detection of Malignant and Benign Lesions by Static 18F-Fluoride PET and PET/CT
18F-fluoride PET is the most sensitive imaging modality for detection of malignant bone involvement.27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42 The regional clearance of 18F fluoride from plasma to bone is 3-fold or greater in metastatic lesions than in normal bone.3 Schirrmeister and coworkers have shown, in several reports, the superiority of 18F-fluoride–PET for the detection of metastatic skeletal involvement compared with 99mTc-MDP bone scintigraphy (BS).29, 30, 32, 35
References (50)
- et al.
18F-fluoride for bone imaging
Semin Nucl Med
(1972) - et al.
Quantitative studies of bone with the use of F18-fluoride and Tc99m-methylene diphosphonate
Semin Nucl Med
(2001) - et al.
Monitoring of graft perfusion and osteoblast activity in revascularised fibula segments using [18F]-positron emission tomography
Int J Oral Maxillofac Surg
(1999) - et al.
The role of positron emission tomography in skeletal disease
Semin Nucl Med
(2001) Current status of PET in breast cancer imaging, staging, and therapy
Semin Roentgenol
(2001)- et al.
Current and future uses of positron emission tomography in breast cancer imaging
Semin Nucl Med
(2004) - et al.
Positron emission tomography for prostate, bladder, and renal cancer
Semin Nucl Med
(2004) - et al.
Positron emission tomography and bone metastases
Semin Nucl Med
(2005) - et al.
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast
Semin Nucl Med
(2006) - et al.
The role of [18F]fluoride positron emission tomography in the early detection of aseptic loosening of total knee arthroplasty
Int J Surg
(2007)